State Street Corp Increases Stake in Addus HomeCare Co. (NASDAQ:ADUS)

State Street Corp grew its position in Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 4.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 663,610 shares of the company’s stock after acquiring an additional 27,990 shares during the quarter. State Street Corp owned about 3.66% of Addus HomeCare worth $88,280,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. UMB Bank n.a. boosted its position in shares of Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after buying an additional 88 shares during the period. Quarry LP bought a new stake in shares of Addus HomeCare during the 3rd quarter worth approximately $28,000. Quest Partners LLC purchased a new position in Addus HomeCare during the 2nd quarter valued at $31,000. Innealta Capital LLC bought a new position in Addus HomeCare in the 2nd quarter valued at $44,000. Finally, Farther Finance Advisors LLC increased its stake in Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after purchasing an additional 366 shares during the period. Institutional investors own 95.35% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Macquarie restated an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a report on Monday, November 4th. Oppenheimer upped their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. JMP Securities assumed coverage on shares of Addus HomeCare in a research report on Monday. They set an “outperform” rating and a $150.00 target price on the stock. Stephens increased their price objective on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. Finally, KeyCorp started coverage on Addus HomeCare in a report on Friday, October 11th. They set an “overweight” rating and a $150.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $133.67.

View Our Latest Stock Analysis on ADUS

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $130.41 on Tuesday. The business has a fifty day moving average price of $125.76 and a 200 day moving average price of $124.69. Addus HomeCare Co. has a 1-year low of $85.94 and a 1-year high of $136.12. The stock has a market capitalization of $2.36 billion, a P/E ratio of 29.84, a price-to-earnings-growth ratio of 2.11 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last released its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company’s revenue was up 7.1% compared to the same quarter last year. During the same period last year, the business earned $1.03 EPS. As a group, equities research analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the sale, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the transaction, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 4.60% of the company’s stock.

Addus HomeCare Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Recommended Stories

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.